Teicoplanin
- IVTeicoplaninAlternative to vancomycin if severe red man syndrome
Mechanism of Action
- Inhibits bacterial cell wall peptidoglycan synthesis.
Microbiology
- Broad cover against gram positive organisms, including Methicillin resistant Staphylococcus aureus (MRSA) and methicillin-resistant coagulase negative staphylococci.
Clinical Use
- Indications
- Proven MRSA
- Life-threatening staphylococcal infections
- Enterococcal endocarditis
- Adverse Effects
- Anaphylaxis
- Nausea / vomiting / diarrhoea
- Nephrotoxicity (rarely)
Monitoring
- To ensure therapeutic levels, check serum concentration before the fourth dose.